Yang, Heng
Xia, Lin
Chen, Jian
Zhang, Shuqing
Martin, Vincent
Li, Qingqing
Lin, Shangqing
Chen, Jinfeng
Calmette, Joseph
Lu, Min http://orcid.org/0000-0001-6902-3751
Fu, Lingyi
Yang, Jie
Pan, Zhizhong
Yu, Kuai
He, Jingjing
Morand, Eric http://orcid.org/0000-0002-9507-3338
Schlecht-Louf, Géraldine http://orcid.org/0000-0002-7924-5371
Krzysiek, Roman
Zitvogel, Laurence
Kang, Boxi http://orcid.org/0000-0002-0276-0519
Zhang, Zeming http://orcid.org/0000-0003-3789-6536
Leader, Andrew
Zhou, Penghui
Lanfumey, Laurence http://orcid.org/0000-0002-4725-2737
Shi, Minxin
Kroemer, Guido http://orcid.org/0000-0002-9334-4405
Ma, Yuting http://orcid.org/0000-0001-6267-1852
Article History
Received: 15 April 2018
Accepted: 31 July 2019
First Online: 9 September 2019
Competing interests
: L.Z. and G.K. are founders and shareholders of EVERIMMUNE. The other authors declare no competing interests.